Non-Current Assets
Other Non-Current Assets
Merck & Co. Other Non-Current Assets increased by 5.3% to $19.81B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.1%, from $16.77B to $19.81B. Over 3 years (FY 2022 to FY 2025), Other Non-Current Assets shows an upward trend with a 25.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026May 4, 2026
How to read this metric
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
Detailed definition
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Peer comparison
Varies widely by company; usually represents a small percentage of total assets.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.53B | $10.56B | $12.00B | $12.33B | $12.70B | $14.44B | $16.04B | $16.77B | $17.66B | $18.33B | $18.82B | $19.81B |
| QoQ Change | — | +10.8% | +13.6% | +2.8% | +3.1% | +13.7% | +11.1% | +4.5% | +5.3% | +3.8% | +2.6% | +5.3% |
| YoY Change | — | — | +25.9% | — | — | +36.8% | +33.7% | +36.0% | +39.1% | +26.9% | +17.3% | +18.1% |
Range$9.53B – $19.81B
CAGR+30.5%
Avg YoY Growth+29.2%
Median YoY Growth+30.3%
Current Streak11+ quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s other non-current assets?
- Merck & Co. (MRK) reported other non-current assets of $19.81B in Q1 2026.
- How has Merck & Co.'s other non-current assets changed year-over-year?
- Merck & Co.'s other non-current assets increased by 18.1% year-over-year, from $16.77B to $19.81B.
- What is the long-term trend for Merck & Co.'s other non-current assets?
- Over 3 years (2022 to 2025), Merck & Co.'s other non-current assets has grown at a 25.5% compound annual growth rate (CAGR), from $9.53B to $18.82B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard reporting categories.